Sage Journals: Discover world-class research

Retricted access

Research article

First published 2002-12

Quantitative Radioimmunoimaging for Radioimmunotherapy Treatment Planning: Effect of Reduction in Data Sampling on Dosimetric Estimates

W. D. Erwin, M. W. Groch

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2015-09

Population-Based Modeling Improves Treatment Planning Before 90 Y-Labeled Anti-CD66 Antibody Radioimmunotherapy

Christian Maaß, Peter Kletting, Donald Bunjes [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1991-10

Radioimmunotherapy for Breast Cancer: Treatment of a Patient with I-131 L6 Chimeric Monoclonal Antibody

S.J. Denardo, K.A. Warhoe, L.F. O'grady [...]

The International Journal of Biological Markers

Retricted access

Research article

First published 2008-02

Cancer Stem Cell Targeting Using the Alpha-Particle Emitter,213 Bi: Mathematical Modeling and Feasibility Analysis

George Sgouros, Hong Song

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2009-02

Development and Evaluation of a Pharmacokinetic Model for Prediction of Radioimmunotherapy Based on Pretherapy Data

Mattias Nickel, Sven-Erik Strand, Ola Lindén [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1993-7

Radioimmunotherapy of Ovarian Cancer

F. Crippa

The International Journal of Biological Markers

Retricted access

Research article

First published 2012-09

Prediction of Therapy Tumor-Absorbed Dose Estimates in I-131 Radioimmunotherapy Using Tracer Data Via a Mixed-Model Fit to Time Activity

Matthew J. Schipper, Kenneth F. Koral, Anca M. Avram [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2022-04

Perspectives on Internal Dosimetry for Optimized Radionuclide Therapy

Darrell R. Fisher

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2026

Evaluation of RC48-ADC in Combination with PRaG Regimen: An Open-Label,Prospective,Multicentre Study Assessing Efficacy and Safety for Advanced Refractory HER2-Expressing Solid Tumors (PRaG3.0 Study Protocol)

Meiling Xu, Yuehong Kong, Junjun Zhang [...]

Technology in Cancer Research & Treatment

Retricted access

Case report

First published 2009-04

The Role of Dosimetry in the High Activity 90 Y-Ibritumomab Tiuxetan Regimens: Two Cases of Abnormal Biodistribution

Demetrio Aricò, Chiara Maria Grana, Anna Vanazzi [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results